2Alex P, Szodoray P, Arthur E, et al. Influence of in- traarticular corticosteroid administration on serum cyto- kines in rheumatoid arthritis[ J]. Clin Rheumatol, 2007, 26 ( 5 ) : 845-848.
3Okada Y, Nagase H, Harris E D, et al. A metalloprotei- nase from human rheumatoid synovial fibroblasts that di- gests connective tissue matrix components. Purification and characterization[ J ]. J Biol Chem, 1986,261 ( 30 ) : 14245-14255.
4Han Z, Boyle D L, Chang L, et al. c-Jun N-terminal ki- nase is required for metalloproteinase expression and joint destruction in inflammatory arthritis [ J]. J Clin Invest, 2001,108( 1 ) :73-81.
5DiBattista J A, Martel Pelletier J, Wosu L O, et al. Glu- cocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal hu-man chondrocytes[ J]. J Clin Endocrinol Metab, 1991,72 (2) :316-326.
6Mamehara A, Sugimoto T, Sugiyama D, et al. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological dis- ease modifying anti-rheumatic drugs [ J ]. Kobe J Med Sci, 2010,56(3) :98-107.
7Grom A A, Murray K J, Luyrink L, et al. Patterns of ex- pression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthrop- athy[ J]. Arthritis Rheum, 1996,39(10) :1703-1710.
8Sugano M, Tsuchida K, Tomita H, et al. Increased pro- liferation of endothelial cells with overexpression of solu- ble TNF-alpha receptor I gene [ J ]. Atherosclerosis, 2002, 162( 1 ) :77-84.
9Lagnocco A, Cerioni A, Coari G, et al. Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study [ J ]. Clin Rheumatol, 2006,25 (2) : 159-163.
10Kane D, Gogarty M, Oleary J, et al. Reduction of syno- vial sublining layer inflammation and proinflammatory cy- tokine expression in psoriatic arthritis treated with metho- trexate [ J ]. Arthritis Rheum, 2004,50 ( 10 ) : 3286-3295.
